Collaborative and translational research is a cornerstone of advancing the science of veterinary medicine at UC Davis. Three scientists at the university are taking regenerative medicine to new heights.
Thanks to a university-wide collaboration between veterinarians, physicians, researchers, and biomedical engineers, a groundbreaking clinical trial has been approved in human medicine to treat spina bifida with stem cells.
Since 2012, the Veterinary Institute for Regenerative Cures (VIRC) at the UC Davis School of Veterinary Medicine (SVM) has been committed to transforming the SVM into a national leader for veterinary regenerative medicine. VIRC has established laboratory techniques and animal models that have been used to study regenerative therapies for veterinary and human medicine. It has characterized equine, canine and feline stem cells isolated from different tissues with a focus on adult-derived mesenchymal stem cells.
